

Senate
File
267
-
Introduced


SENATE
FILE
267


BY
SENG


A
BILL
FOR


An
Act
creating
a
tax
credit
available
for
the
individual
1


and
corporate
income
taxes,
the
franchise
tax,
insurance
2


premiums
tax,
and
the
moneys
and
credits
tax
for
a
3


charitable
contribution
to
certain
institutions
engaged
in
4


regenerative
medicine
research
and
including
retroactive
5


applicability
provisions.
6


BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
7


TLSB
2098SS
(1)
85


mm/sc



S.F.
267


Section
1.
NEW
SECTION
.
422.11E
Regenerative
medicine
1


research
tax
credit.
2


1.
a.
The
taxes
imposed
under
this
division,
less
the
3


credits
allowed
under
section
422.12,
shall
be
reduced
by
a
4


regenerative
medicine
research
tax
credit.
5


b.
The
credit
shall
be
in
an
amount
equal
to
sixty
percent
6


of
a
taxpayer’s
charitable
contribution
to
an
eligible
research
7


institution
located
in
the
state.
For
purposes
of
this
8


section,
“eligible
research
institution”
means
an
organization
9


qualifying
under
section
501(c)(3)
of
the
Internal
Revenue
Code
10


as
an
organization
exempt
from
federal
income
tax
under
section
11


501(a)
of
the
Internal
Revenue
Code
that
is
engaged
in
research
12


designed
to
improve
patient
care
through
the
development
and
13


dissemination
of
novel
clinical
therapies
for
the
functional
14


repair
and
replacement
of
diseased
tissues
and
organs,
15


including
research
for
the
treatment
of
cancer.
“Eligible
16


research
institution”
excludes
a
postsecondary
institution
or
an
17


entity
or
organization
receiving
twenty-five
percent
or
more
of
18


its
annual
budget
from
a
postsecondary
institution.
19


c.
An
individual
may
claim
a
tax
credit
under
this
20


subsection
of
a
partnership,
limited
liability
company,
21


S
corporation,
estate,
or
trust
electing
to
have
income
22


taxed
directly
to
the
individual.
The
amount
claimed
by
the
23


individual
shall
be
based
upon
the
pro
rata
share
of
the
24


individual’s
earnings
from
the
partnership,
limited
liability
25


company,
S
corporation,
estate,
or
trust.
26


d.
Any
tax
credit
in
excess
of
the
taxpayer’s
tax
liability
27


for
the
tax
year
is
not
refundable,
but
the
taxpayer
may
28


elect
to
have
the
excess
credited
to
the
tax
liability
for
29


the
following
four
tax
years
or
until
depleted,
whichever
is
30


earlier.
31


2.
a.
To
claim
a
tax
credit
under
this
section,
the
32


taxpayer
shall
apply
to
the
department
for
a
tax
credit
33


certificate.
After
verifying
the
eligibility
of
a
taxpayer
for
34


a
tax
credit
pursuant
to
this
section,
the
department
shall
35


-1-


LSB
2098SS
(1)
85


mm/sc
1/
4




S.F.
267


issue
a
tax
credit
certificate
to
be
attached
to
the
taxpayer’s
1


tax
return.
The
tax
credit
certificate
shall
be
issued
on
2


a
first-come,
first-served
basis
based
upon
the
date
of
the
3


application
and
shall
contain
the
taxpayer’s
name,
address,
4


tax
identification
number,
the
amount
of
the
credit,
the
5


certificate
expiration
date,
and
any
other
information
required
6


by
the
department.
7


b.
To
claim
a
tax
credit
under
this
section,
a
taxpayer
must
8


attach
one
or
more
tax
credit
certificates
to
the
taxpayer’s
9


tax
return.
The
tax
credit
certificate
or
certificates
10


attached
to
the
taxpayer’s
tax
return
shall
be
issued
in
the
11


taxpayer’s
name,
and
the
expiration
date
on
the
certificate
12


shall
be
a
date
that
falls
on
or
after
the
last
day
of
the
13


taxable
year
for
which
the
taxpayer
is
claiming
the
tax
credit.
14


c.
The
tax
credit
certificate,
unless
otherwise
void,
15


shall
be
accepted
by
the
department
as
payment
toward
the
16


tax
liability
of
the
taxpayer,
subject
to
any
conditions
or
17


restrictions
placed
by
the
department
upon
the
face
of
the
18


tax
credit
certificate
and
subject
to
the
limitations
of
this
19


section.
20


d.
Tax
credit
certificates
issued
under
this
section
are
not
21


transferable
to
any
person
or
entity.
22


3.
The
maximum
amount
of
tax
credits
issued
in
a
fiscal
23


year
pursuant
to
this
section,
section
422.33,
subsection
30,
24


section
422.60,
subsection
12,
section
432.12N,
and
section
25


533.329,
subsection
2,
paragraph
“k”
,
shall
not
exceed
ten
26


million
dollars.
27


Sec.
2.
Section
422.33,
Code
2013,
is
amended
by
adding
the
28


following
new
subsection:
29


NEW
SUBSECTION


.
30.
The
taxes
imposed
under
this
division
30


shall
be
reduced
by
a
regenerative
medicine
research
tax
credit
31


in
the
same
manner,
for
the
same
amount,
and
under
the
same
32


conditions
as
provided
in
section
422.11E.
33


Sec.
3.
Section
422.60,
Code
2013,
is
amended
by
adding
the
34


following
new
subsection:
35


-2-


LSB
2098SS
(1)
85


mm/sc
2/
4




S.F.
267


NEW
SUBSECTION
.
12.
The
taxes
imposed
under
this
division
1


shall
be
reduced
by
a
regenerative
medicine
research
tax
credit
2


in
the
same
manner,
for
the
same
amount,
and
under
the
same
3


conditions
as
provided
in
section
422.11E.
4


Sec.
4.
NEW
SECTION


.
432.12N
Regenerative
medicine
research
5


tax
credit.
6


The
taxes
imposed
under
this
chapter
shall
be
reduced
by
a
7


regenerative
medicine
research
tax
credit
in
the
same
manner,
8


for
the
same
amount,
and
under
the
same
conditions
as
provided
9


in
section
422.11E.
10


Sec.
5.
Section
533.329,
subsection
2,
Code
2013,
is
amended
11


by
adding
the
following
new
paragraph:
12


NEW
PARAGRAPH
.
k.
The
moneys
and
credits
tax
imposed
13


under
this
section
shall
be
reduced
by
a
regenerative
medicine
14


research
tax
credit
in
the
same
manner,
for
the
same
amount,
15


and
under
the
same
conditions
as
provided
in
section
422.11E.
16


Sec.
6.
RETROACTIVE
APPLICABILITY.
This
Act
applies
17


retroactively
to
January
1,
2013,
for
tax
years
beginning
on
18


or
after
that
date.
19


EXPLANATION
20


This
bill
provides
a
credit
against
the
individual
or
21


corporate
income
tax,
the
franchise
tax,
the
insurance
premiums
22


tax,
and
the
moneys
and
credits
tax
for
60
percent
of
a
23


taxpayer’s
contribution
to
a
regenerative
medicine
research
24


institution
located
in
the
state.
In
order
to
qualify
for
the
25


credit,
the
regenerative
medicine
research
institute
must
be
26


qualified
under
501(c)(3)
of
the
Internal
Revenue
Code
and
must
27


engage
in
research
that
is
designed
to
improve
patient
care
28


through
the
development
and
dissemination
of
novel
clinical
29


therapies
for
the
functional
repair
and
replacement
of
diseased
30


tissues
and
organs,
including
cancer
research.
Postsecondary
31


institutions
and
entities
that
receive
25
percent
or
more
of
32


their
annual
budget
from
a
postsecondary
institution
do
not
33


qualify.
34


The
tax
credit
is
not
refundable
but,
at
the
taxpayer’s
35


-3-


LSB
2098SS
(1)
85


mm/sc
3/
4






S.F.
267


election,
may
be
credited
to
the
taxpayer’s
tax
liability
for
1


up
to
four
subsequent
tax
years
or
until
depletion,
whichever
2


is
earlier.
The
tax
credits
are
not
transferable.
The
maximum
3


amount
of
tax
credits
is
limited
to
$10
million
in
any
one
4


fiscal
year.
The
department
of
revenue
approves
the
tax
5


credits
and
issues
the
tax
credit
certificates
to
taxpayers.
6


The
bill
applies
retroactively
to
January
1,
2013,
for
tax
7


years
beginning
on
or
after
that
date.


8


-4-


LSB
2098SS
(1)
85


mm/sc
4/
4

